Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs

Showing results (11-20 of 294) with videos related to

Pageof 30
Sort By:
Lancet (London, England)|August 17, 2010
Rimonabant: obituary for a wonder drugS Matthijs Boekholdt, Ron J G Peters
Lancet (London, England)|March 17, 2012
The interleukin-6 pathway and atherosclerosisS Matthijs Boekholdt, Erik S G Stroes
Current Opinion in Lipidology|January 19, 2016
Non-high-density lipoprotein cholesterol: current status as cardiovascular markerRutger Verbeek, G Kees Hovingh, S Matthijs Boekholdt
FEMS Microbiology Letters|December 1, 2001
Impact of mutations in hemA and hemH genes on pyoverdine production by Pseudomonas fluorescens ATCC17400C Baysse, S Matthijs, T Pattery, et al.
Journal of the American College of Cardiology|August 19, 2017
Coronary Artery Disease Affects Symptomatology of Aortic Valve StenosisS Matthijs Boekholdt, Benoit J Arsenault, Patrick Mathieu
Journal of Clinical Periodontology|April 4, 2001
Intra-examiner reproducibility of 4 dental plaque indicesS Matthijs, M M Sabzevar, P A Adriaens
Circulation|August 5, 2015
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?G Kees Hovingh, Kausik K Ray, S Matthijs Boekholdt
Lancet (London, England)|September 2, 2017
Very low LDL-cholesterol concentrations achieved: which target is next?G Kees Hovingh, S Matthijs Boekholdt, Erik S Stroes
Journal of the American College of Cardiology|March 19, 2013
Reply: To PMID 23219296David D Waters, S Matthijs Boekholdt, Terje R Pedersen
Research in Microbiology|February 24, 2001
The trehalose operon of Pseudomonas fluorescens ATCC 17400S Matthijs, N Koedam, P Cornelis, et al.
Pageof 30

Showing results (11-20 of 294) with videos related to

Sort By:
Pageof 30
Lancet (London, England)|August 17, 2010
Rimonabant: obituary for a wonder drugS Matthijs Boekholdt, Ron J G Peters
Lancet (London, England)|March 17, 2012
The interleukin-6 pathway and atherosclerosisS Matthijs Boekholdt, Erik S G Stroes
Current Opinion in Lipidology|January 19, 2016
Non-high-density lipoprotein cholesterol: current status as cardiovascular markerRutger Verbeek, G Kees Hovingh, S Matthijs Boekholdt
FEMS Microbiology Letters|December 1, 2001
Impact of mutations in hemA and hemH genes on pyoverdine production by Pseudomonas fluorescens ATCC17400C Baysse, S Matthijs, T Pattery, et al.
Journal of the American College of Cardiology|August 19, 2017
Coronary Artery Disease Affects Symptomatology of Aortic Valve StenosisS Matthijs Boekholdt, Benoit J Arsenault, Patrick Mathieu
Journal of Clinical Periodontology|April 4, 2001
Intra-examiner reproducibility of 4 dental plaque indicesS Matthijs, M M Sabzevar, P A Adriaens
Circulation|August 5, 2015
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?G Kees Hovingh, Kausik K Ray, S Matthijs Boekholdt
Lancet (London, England)|September 2, 2017
Very low LDL-cholesterol concentrations achieved: which target is next?G Kees Hovingh, S Matthijs Boekholdt, Erik S Stroes
Journal of the American College of Cardiology|March 19, 2013
Reply: To PMID 23219296David D Waters, S Matthijs Boekholdt, Terje R Pedersen
Research in Microbiology|February 24, 2001
The trehalose operon of Pseudomonas fluorescens ATCC 17400S Matthijs, N Koedam, P Cornelis, et al.
Pageof 30